Global Acute Bacterial Skin And Skin Structure Infections Market Report 2026–2030: Data-Driven Growth Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the acute bacterial skin and skin structure infections market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Acute Bacterial Skin And Skin Structure Infections Market in 2030?
The acute bacterial skin and skin structure infections market has experienced robust expansion in recent years. Its size is projected to increase from $12.9 billion in 2025 to $14.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.2%. Historically, this growth has been driven by factors such as the restricted supply of broad-spectrum antibiotics, an uptick in hospital-acquired infections, greater understanding of skin infection complications, enhanced community healthcare accessibility, and the implementation of standard infection control measures.
The acute bacterial skin and skin structure infections market size is anticipated to expand significantly in the coming years, reaching $20.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. This growth during the forecast period is attributable to several factors, including the advancement of next-generation antibiotics, increased funding for antimicrobial research, the expansion of community-based infection management initiatives, broadening hospital pharmacy distribution networks, and the adoption of rapid diagnostic technologies. Key trends expected within this period encompass a rise in the incidence of acute bacterial skin and skin structure infections, the increasing use of new antibiotics and combination treatments, the enlargement of both hospital and community healthcare infrastructure, a greater reliance on oral and parenteral antibiotics, and a concerted effort to lower hospital-acquired infection rates.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13282&type=smp
What Drivers Are Influencing Production Trends In The Acute Bacterial Skin And Skin Structure Infections Market?
The increasing occurrence of skin infections is anticipated to boost the expansion of the acute bacterial skin and skin structure infections market. These conditions involve microorganisms like bacteria, fungi, or viruses infiltrating and multiplying in the skin, causing various symptoms and discomfort. A surge in skin infections generates a greater need for therapeutic interventions, antibiotics, and advanced treatments for acute bacterial and skin structure infections, aiming to provide optimal patient care. For example, in March 2023, the World Health Organization reported that approximately 1.8 billion individuals worldwide experience skin conditions at any given time. Of these, neglected tropical diseases (NTDs) constitute about 10%, fungal infections 34%, and bacterial infections 23%, frequently resulting in high mortality rates. Consequently, the growing prevalence of skin infections will stimulate the growth of the acute bacterial skin and skin structure infections market.
Which Segments Are Gaining Traction In The Acute Bacterial Skin And Skin Structure Infections Market?
The acute bacterial skin and skin structure infections market covered in this report is segmented –
1) By Type Of Infection: Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections, Community-Acquired Acute Bacterial Skin And Skin Structure Infections
2) By Active Ingredients: Delafloxacin, Vancomycin, Ceftaroline Fosamil, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, Other Active Ingredients
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections (HABSSSIs): Surgical Site Infections, Catheter-Related Infections, Infections Related To Medical Devices
2) By Community-Acquired Acute Bacterial Skin And Skin Structure Infections (CABSSSIs): Cellulitis, Abscesses, Impetigo, Folliculitis, Wound Infections
What Trends Are Projected To Support The Growth Of The Acute Bacterial Skin And Skin Structure Infections Market?
Major companies active in the acute bacterial skin and skin structure infections market are focusing on the development of innovative single-dose therapies, such as Dalbonova, to gain a competitive advantage. Dalbonova is a single-dose treatment designed to offer convenience and effectiveness, enabling patients to achieve desired results with a potent 1500 mg dose administered only once. For example, in August 2023, BDR Pharmaceuticals International Pvt. Ltd., an India-based pharmaceutical company specializing in API (active pharmaceutical ingredient) and formulation therapeutic segments, including acute bacterial skin and skin structure infections, launched Dalbonova injection, a single-dose therapy for acute bacterial skin and skin structure infections (ABSSSI). Dalbonova Injection reduces the likelihood of hospital-acquired diseases by providing a single-dose regimen and removing the requirement for hospital admissions. It is developed to treat acute bacterial skin and skin structure infections (ABSSSI) caused by certain gram-positive microorganisms in patients across all age categories, including newborns.
Who Are The Primary Competitors In The Global Acute Bacterial Skin And Skin Structure Infections Market?
Major companies operating in the acute bacterial skin and skin structure infections market are Pfizer Inc., AbbVie Inc., Novartis AG, GSK PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited, Aspen Pharmacare Holdings Limited, Melinta Therapeutics LLC, Abbott Laboratories, Fresenius SE & Co. KGaA, Menarini Group
Access The Complete Report For Deeper Market Insights:
Which Global Regions Are Shaping The Competitive Landscape Of The Acute Bacterial Skin And Skin Structure Infections Market?
Asia-Pacific was the largest region in the acute bacterial skin and skin structure infections market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the acute bacterial skin and skin structure infections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Acute Bacterial Skin And Skin Structure Infections Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13282&type=smp
Browse Through More Reports Similar to the Global Acute Bacterial Skin And Skin Structure Infections Market 2026, By The Business Research Company
Dermatitis Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report
Complicated Skin And Skin Structure Infections Drugs Market Report 2026
Antimicrobial Medical Device Coatings Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
